Dr. Vega is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
234 E 85th St
New York, NY 10028Phone+1 212-241-6585Fax+1 212-731-3391
Education & Training
- University of ConnecticutResidency, Internal Medicine, 1981 - 1983
- St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1980 - 1981
- Boston University School of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 1994 - 2025
- NY State Medical License 2009 - 2025
- TX State Medical License 2019 - 2025
- CT State Medical License 1983 - 1998
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2013-2014
- New York Magazine: Top Doctors Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- 159 citationsBarriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staffJennifer McNeely, Pritika C. Kumar, Traci Rieckmann, Erica Sedlander, Sarah Farkas
Addiction Science & Clinical Practice. 2018-04-09 - 3 citationsPrescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program.Aniwaa Owusu Obeng, Stuart A Scott, Tom Kaszemacher, Stephen B Ellis, Ana Mejia
Clinical Pharmacology and Therapeutics. 2023-02-01 - 32 citationsComparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.Jennifer McNeely, Angéline Adam, John Rotrosen, Sarah E. Wakeman, Timothy E. Wilens
JAMA Network Open. 2021-05-03
Press Mentions
- 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease PatientsJune 20th, 2022
- The Mount Sinai Medical Center Received a High Safety Rating in TheJuly 28th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: